Department of Endocrinology, Provincial Hospital Affiliated to Shandong University, Jinan, China; Department of Endocrinology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, China.
Clin Endocrinol (Oxf). 2014 Apr;80(4):585-90. doi: 10.1111/cen.12311. Epub 2013 Sep 23.
Thyroid hormones disorders are associated with changes of body composition. However, the relationship between thyroid hormones and body fat in a euthyroid population is unclear. The aim of this study was to explore the association between thyroid hormones and body fat in a euthyriod population.
A total of 865 euthyroid individuals were recruited in this study. Subjects with thyroid diseases or diabetes and who were taking medications that could influence thyroid hormones, weight or glucose metabolism were excluded.
FT3, FT4, lipid parameters, fasting insulin (FINS) and blood glucose were determined, and homeostasis model assessment for insulin resistance (HOMA-IR) was calculated. Anthropometric measurements were taken, and body fat parameters were assessed.
Serum FT3 was slightly higher in body mass index (BMI) ≥25 kg/m(2) group than that in BMI <25 kg/m(2) group (P < 0·05). However, the difference was too small to have clinical significance. FT4 levels were not significantly different between the two groups. Body weight, BMI, waist circumference, hip circumference, waist-to-hip ratio (WHR), percentage of body fat (PBF), waist-fat-to-hip-fat ratio, FINS and HOMA-IR increased linearly with the elevation of FT3 adjusted for age and gender. A multivariate linear regression analysis revealed that fat mass, PBF, HOMA-IR and FT4 contributed significantly to FT3 levels.
Grouped according to BMI, overweight and obese subjects have similar thyroid hormones compared to those with normal weight. Body composition parameters increase with the elevation of FT3, and FT3 is associated with body fat parameters in euthyroid subjects.
甲状腺激素紊乱与身体成分变化有关。然而,甲状腺激素与甲状腺功能正常人群体脂肪之间的关系尚不清楚。本研究旨在探讨甲状腺功能正常人群中甲状腺激素与体脂之间的关系。
本研究共纳入 865 例甲状腺功能正常个体。排除患有甲状腺疾病或糖尿病且正在服用可能影响甲状腺激素、体重或葡萄糖代谢的药物的患者。
测定 FT3、FT4、血脂参数、空腹胰岛素(FINS)和血糖,并计算胰岛素抵抗的稳态模型评估(HOMA-IR)。测量人体测量学指标,并评估体脂参数。
BMI≥25kg/m2 组的血清 FT3 略高于 BMI<25kg/m2 组(P<0.05)。然而,这种差异太小,没有临床意义。两组之间 FT4 水平无显著差异。体重、BMI、腰围、臀围、腰臀比(WHR)、体脂百分比(PBF)、腰围脂肪与臀围脂肪比、FINS 和 HOMA-IR 随 FT3 的升高呈线性增加,校正年龄和性别后。多元线性回归分析显示,脂肪量、PBF、HOMA-IR 和 FT4 对 FT3 水平有显著影响。
根据 BMI 分组,超重和肥胖患者的甲状腺激素与体重正常者相似。身体成分参数随 FT3 的升高而增加,FT3 与甲状腺功能正常个体的体脂参数相关。